DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma

Glioblastomas are the most common primary central nervous system malignancy tumor in adults. Glioblastoma patients have poor prognosis, with an average survival period of approximately 14 mo after diagnosis. To date, there are a limited number of effective treatment methods for glioblastoma, and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yunliang, Qing, Cheng, Wang, Jiao, Zeng, Zhenguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563836/
https://www.ncbi.nlm.nih.gov/pubmed/32510239
http://dx.doi.org/10.1177/0963689720933241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563836/
https://www.ncbi.nlm.nih.gov/pubmed/32510239
http://dx.doi.org/10.1177/0963689720933241

Ejemplares similares